期刊文献+

沉默DNMT1和DNMT3b基因对胰腺癌BxPC-3细胞p16,RASSF1A基因启动子甲基化的影响 被引量:3

Effect of gene silencing of DNMT1 and DNMT3b on the methylation in the promoter region of p16 and RASSF1A gene in pancreatic carcinoma BxPC-3 cells
原文传递
导出
摘要 目的:探讨沉默DNMT1和DNMT3b基因对胰腺癌BxPC-3细胞p16,RASSF1A基因启动子甲基化的影响。方法:将胰腺癌BxPC-3细胞分为5组:DNMT1干扰组(转染DNMT1-siRNA),DNMT3b干扰组(转染DNMT3b-siRNA),双重干扰组(转染DNMT1+DNMT3b-siRNA),阴性对照组(转染阴性siRNA)和空白对照组(转染脂质体)。转染48 h后,应用荧光定量PCR法和Western blot法分别检测细胞中DNMT1和DNMT3b的mRNA及蛋白的表达水平;甲基化特异性PCR法检测p16和RASSF1A基因启动子甲基化。结果:与空白对照组和阴性对照组比较,各干扰组目的基因的mRNA及蛋白表达量均明显降低(均P<0.01)。空白对照组与阴性对照组p16和RASSF1A基因甲基化阳性;DNMT1干扰组和双重干扰组p16基因甲基化阴性,RASSF1A基因部分甲基化;DNMT3b干扰组p16基因部分甲基化,RASSF1A基因甲基化阳性。结论:DNMT1单干扰对胰腺癌BxPC-3细胞p16和RASSF1A基因的去甲基化作用优于DNMT3b单干扰,DNMT1和DNMT3b双重干扰无明显的协同效应;提示DNMT1是胰腺癌去甲基化治疗的一个有效靶点。 Objective: To investigate the effect of gene silencing of DNMT1 and DNMT3b on methylation in the promoter region of p16 and RASSF1A gene in pancreatic carcinoma BxPC-3 cells. Methods: The pancreatic carcinoma BxPC-3 cells were divided into five groups,which included the DNMT1 interference group(transfected with DNMT1-siRNA),DNMT3b interference group(transfected with DNMT3b-siRNA),double interference group(transfected with DNMT1+DNMT3b-siRNA),negative control group(transfected negative-siRNA) and blank control group(transfected with lipofectamine).Forty-eight hours after transfection,the mRNA and protein expression of DNMT1 and DNMT3b were analyzed by real-time RT-PCR and Western blot,and the methylation status in the promoter region of p16 and RASSF1A gene was detected with methylation-specific PCR(MSP). Results: Compared with the negative or blank control group,the mRNA and protein expression levels of the targeted genes were all markedly down-regulated in each interference group(all P0.01).The methylation status of p16 and RASSF1A gene was positive in both the blank and negative control group;the p16 gene was unmethylated and RASSF1A gene was partially methylated in DNMT1 interference group and double interference group;the p16 gene was partially methylated and RASSF1A gene showed methylation-positive state in DNMT3b interference group. Conclusion: DNMT1 interference has better effect than DNMT3b interference on demethylation in BxPC-3 cells,and the double knockdown of DNMT1 and DNMT3b exerts no synergistic action.DNMT1 could serve as an effective target for the demethylation therapy of pancreatic carcinoma.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第3期322-326,共5页 China Journal of General Surgery
基金 江西省教育厅科学技术研究项目(GJJ08077)
关键词 胰腺肿瘤 DNA甲基化 RNA干扰 基因 p16 基因 RASSF1A Pancreatic Neoplasms DNA Methylation RNA Interference Genes p16 Genes RASSF1A
  • 相关文献

参考文献15

  • 1Kuroki T, Tajima Y, Kanematsu T. Role of hypermethylation on carcinogenesis in the pancreas[J]. Surg Today, 2004, 34(12):981- 986.
  • 2Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells[J]. Nature, 2002, 416(6880):552-556.
  • 3Leu YW, Rahmatpanah F, Shi H, et al. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation[J]. Cancer Res, 2003, 63(19):6110-6115.
  • 4Fukushima N, Sato N, Ueki T, et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma[J]. Am J Pathol, 2002, 160(5):1573-1581.
  • 5杨卫华,王春友,朱求实,阎雷,许州.胰腺癌中p16基因甲基化改变及其蛋白表达分析[J].中国普通外科杂志,2007,16(5):446-450. 被引量:6
  • 6Dammann R, Schagdarsurengin U, Liu L, et al. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma[J]. Oncogene, 2003, 22(24):3806-3812.
  • 7武林枫,王逢春,马玉刚,翟博,赵福龙,孟庆辉.抑癌基因RASSF1A在胰腺癌组织中表达的研究[J].中国普通外科杂志,2009,18(3):292-294. 被引量:2
  • 8Witkiewicz AK, Knudsen KE, Dicker AP, et al. The meaning of pl6(ink4a) expression in tumors: functional significance, clinicalassociations and future developments[J]. Cell Cycle, 2011, 10(15):2497-2503.
  • 9Shivakumar L, Minna J, Sakamaki T, et al. The RASSFIA tumor suppressor blocks cell cycle progression and inhibits cy~.lin D I accumulation[J]. Mol Cell Biol, 2002, 22(12):4309-4318.
  • 10Vos MD, Martinez A, Elam C, et al. A role for the RASSFI A tumor suppressor in the regulation of tnbulin polymerization and genomic stability[J]. Cancer Res, 2004, 64(12):4244-4250.

二级参考文献23

  • 1张剑英,李智,于永春,段建敏.膀胱癌和肾癌组织中RASSF1A基因的甲基化改变[J].中华泌尿外科杂志,2006,27(S1):9-11. 被引量:7
  • 2安锦霞,杨永秀,黎卫平.RASSF1A基因在宫颈癌组织中的表达及意义[J].第四军医大学学报,2005,26(7):657-660. 被引量:7
  • 3何玉,席玉玲,晋茂生,杜丹丽,王才智.RASSF1A基因在卵巢癌组织及腹腔冲洗液中的表达及意义[J].中国实用妇科与产科杂志,2006,22(1):38-40. 被引量:3
  • 4叶梅,夏冰,郭秋莎,周峰,章晓联.胃癌组织RASSF1A甲基化对其mRNA及蛋白表达的影响[J].中华内科杂志,2006,45(12):1008-1012. 被引量:8
  • 5Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer[J]. Nat Rev Genet, 2002,3(6) : 415- 428.
  • 6Dammann R, Li C, Yoon J H, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3 p21.3 [ J ]. Nat Genet, 2000,25 (3) :315 -319.
  • 7Koen D, Eleanora B, Igor K, et al. The candidate tumor suppressor gene, RASSF 1 A, from human chromosome 3 p21. 3 is involved in kidney tumorigenesis [ J ]. Cancer Res, 2001 ,61(5) : 1682 -1689.
  • 8Dammann R, Schagdarsurengin U, Liu L, et al. Frequent RASSF 1 A promoter hypermethylation and K-ras mutations in pancreatic carcinoma [ J ]. Oncogene, 2003, 22 ( 24 ) : 3806 -3812.
  • 9Marsit CJ, Kim DH, Liu M, et al. Hypermethylation of RASSF1 A and BLU tumor suppressor genes in non-small cell lung cancer: Implications for tobacco smoking during adolescence[J]. Int J Cancer,2005,114(2) : 219 -223.
  • 10Burbee DG, Forgacs E, Zochbauer MS, et al. Epigenetic Inactivation of RASSF 1 A in lung and breast cancers and malignant phenotype suppression [ J ]. J Natl Cancer Inst, 2001, 93(9) :691 -699.

共引文献6

同被引文献40

  • 1张国华,刘士霞.胰腺癌41例误诊因素探讨[J].实用医学杂志,2006,22(23):2804-2805. 被引量:4
  • 2Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 3Jang IK,Zhang J,Gu H.Grb2,a simple adapter with complex roles in lymphocyte development,function,and signaling[J].Immunol Rev,2009,232(1):150-159.
  • 4Giubellino A,Burke TR Jr,Bottaro DP.Grb2 signaling in cell motility and cancer[J].Expert Opin Ther Targets,2008,12(8):1021-1033.
  • 5Feller SM,Lewitzky M.Potential disease targets for drugs that disrupt protein-- protein interactions of Grb2 and Crk family adaptors[J].Curr Pharm Des,2006,12(5):529-548.
  • 6Dharmawardana PG,Peruzzi B,Giubellino A,et al.Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy[J].Anticancer Drugs,2006,17(1):13-20.
  • 7Zhang Y,Wei J,Wang H,et al.Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer[J].Oncol Rep,2012,27(5):1599-1605.
  • 8Ding Q,Yoshimitsu M,Kuwahata T,et al.Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer[J].Hum Cell,2012,25(1):1-8.
  • 9Downward J.The GRB2/Sem-5 adaptor protein[J].FEBS Lett,1994,338(2):113-117.
  • 10Miki H.Ash/Grb2--toward the elucidation of its mechanism to produce a variety of signals[J].Seikagaku,1995,67(2):144-148.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部